HILLENBRAND INDUSTRIES INC
10-Q, 1996-07-11
MISCELLANEOUS MANUFACTURING INDUSTRIES
Previous: GRAY COMMUNICATIONS SYSTEMS INC /GA/, 10-K/A, 1996-07-11
Next: INTERNATIONAL SPEEDWAY CORP, 10-Q, 1996-07-11



<PAGE>

- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------

                                  UNITED STATES


                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C.  20549

                                    FORM 10-Q

                QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
                     OF THE SECURITIES EXCHANGE ACT OF 1934

    FOR THE QUARTERLY PERIOD ENDED JUNE 1, 1996    COMMISSION FILE NO. 1-6651

                          HILLENBRAND INDUSTRIES, INC.
             (Exact name of registrant as specified in its charter)

               INDIANA                                     35-1160484
    (State or other jurisdiction of                     (I.R.S. Employer
    incorporation or organization)                      Identification No.)


       700 STATE ROUTE 46 EAST
         BATESVILLE, INDIANA                                47006-8835
(Address of principal executive offices)                    (Zip Code)

REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE:  (812) 934-7000

                                 NOT APPLICABLE
                     (Former name, former address and former
                   fiscal year, if changed since last report)


     INDICATE BY CHECK MARK WHETHER THE REGISTRANT (1) HAS FILED ALL REPORTS
REQUIRED TO BE FILED BY SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934 DURING THE PRECEDING 12 MONTHS (OR FOR SUCH SHORTER PERIOD THAT THE
REGISTRANT WAS REQUIRED TO FILE SUCH REPORTS), AND (2) HAS BEEN SUBJECT TO SUCH
FILING REQUIREMENTS FOR THE PAST 90 DAYS.

                         Yes   X             No
                            -------            -------

     INDICATE THE NUMBER OF SHARES OUTSTANDING OF EACH OF THE ISSUER'S CLASSES
OF COMMON STOCK, AS OF THE LATEST PRACTICABLE DATE.

Common Stock, without par value - 69,376,980 as of July 5, 1996.


- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------


                                        1

<PAGE>

                          HILLENBRAND INDUSTRIES, INC.

                               INDEX TO FORM 10-Q


                                                                            Page


PART I - FINANCIAL INFORMATION

     Item 1 -  Financial Statements (Unaudited)

               Consolidated Income for the Three Months                     3
                  and Six Months Ended 6/01/96 and 6/03/95

               Consolidated Cash Flows for the Six Months                   4
                  Ended 6/01/96 and 6/03/95

               Consolidated Balance Sheet,                                  5
                  6/01/96 and 12/02/95

               Notes to Consolidated Financial Statements                   6-8

     Item 2 -  Management's Discussion and Analysis of
                  Financial Condition and Results of Operations             8-10


PART II - OTHER INFORMATION

     Item 4 -  Submission of Matters to a Vote                              11
                  of Security Holders

     Item 6 -  Exhibits and Reports on Form 8-K                             11


SIGNATURES                                                                  12


                                        2

<PAGE>

                         PART I - FINANCIAL INFORMATION

ITEM 1.  FINANCIAL STATEMENTS (UNAUDITED)

Hillenbrand Industries, Inc. and Subsidiaries

Consolidated Income

<TABLE>
<CAPTION>

                                                               Three Months Ended              Six Months Ended
                                                            -------------------------     -------------------------
                                                             06/01/96       06/03/95       06/01/96       06/03/95
                                                            ----------     ----------     ----------     ----------
                                                                     (In Thousands Except Per Share Data)
<S>                                                         <C>            <C>            <C>            <C>
Net revenues:
     Health Care sales . . . . . . . . . . . . . . . .      $  143,556     $  137,751     $  292,706     $  268,723
     Health Care rentals . . . . . . . . . . . . . . .          94,461         92,368        189,708        182,622
     Funeral Services  . . . . . . . . . . . . . . . .         132,819        131,157        269,604        261,569
     Insurance . . . . . . . . . . . . . . . . . . . .          53,365         43,583        106,039         88,222
                                                            ----------     ----------     ----------     ----------
     Total revenues  . . . . . . . . . . . . . . . . .         424,201        404,859        858,057        801,136

Cost of revenues:
     Health Care cost of goods sold  . . . . . . . . .          84,106         87,210        175,123        165,262
     Health Care rental expenses . . . . . . . . . . .          60,094         63,075        119,262        123,692
     Funeral Services  . . . . . . . . . . . . . . . .          70,708         69,256        143,887        139,780
     Insurance . . . . . . . . . . . . . . . . . . . .          40,229         32,729         81,017         67,331
                                                            ----------     ----------     ----------     ----------
     Total cost of revenues  . . . . . . . . . . . . .         255,137        252,270        519,289        496,065

Other operating expenses . . . . . . . . . . . . . . .         108,797        104,499        219,998        208,127
                                                            ----------     ----------     ----------     ----------

Operating profit . . . . . . . . . . . . . . . . . . .          60,267         48,090        118,770         96,944

Interest expense . . . . . . . . . . . . . . . . . . .          (6,318)        (5,436)       (12,557)       (10,703)

Other income, net  . . . . . . . . . . . . . . . . . .           2,301          2,256          5,787          3,175
                                                            ----------     ----------     ----------     ----------

Income before income taxes . . . . . . . . . . . . . .          56,250         44,910        112,000         89,416

Income taxes . . . . . . . . . . . . . . . . . . . . .          22,612         17,156         45,024         34,157
                                                            ----------     ----------     ----------     ----------

Net income . . . . . . . . . . . . . . . . . . . . . .      $   33,638     $   27,754     $   66,976     $   55,259
                                                            ----------     ----------     ----------     ----------
                                                            ----------     ----------     ----------     ----------

Net income per common share  . . . . . . . . . . . . .      $      .48     $      .39     $      .96     $      .78
                                                            ----------     ----------     ----------     ----------
                                                            ----------     ----------     ----------     ----------

Dividends per common share . . . . . . . . . . . . . .      $     .155     $      .15     $      .31     $      .30
                                                            ----------     ----------     ----------     ----------
                                                            ----------     ----------     ----------     ----------

Average shares outstanding . . . . . . . . . . . . . .          69,783        70,799          69,957         70,842
                                                            ----------     ----------     ----------     ----------
                                                            ----------     ----------     ----------     ----------
</TABLE>

See Notes to Consolidated Financial Statements


                                        3

<PAGE>

Hillenbrand Industries, Inc. and Subsidiaries

Consolidated Cash Flows

<TABLE>
<CAPTION>

                                                                           Six Months Ended
                                                                      -------------------------
                                                                       06/01/96       06/03/95
                                                                      ----------     ----------
                                                                            (In Thousands)
<S>                                                                   <C>            <C>

Cash flows from operating activities:
  Net income . . . . . . . . . . . . . . . . . . . . . . . . . . .    $   66,976     $   55,259
  Adjustments to reconcile net income
   to net cash flows from operating activities:
    Depreciation and amortization  . . . . . . . . . . . . . . . .        52,966         53,255
    Change in noncurrent deferred
     income taxes  . . . . . . . . . . . . . . . . . . . . . . . .        (1,107)        (3,619)
    Change in net working capital
     excluding cash and current debt . . . . . . . . . . . . . . .         9,402         (7,495)
    Change in insurance items:
     Deferred policy acquisition costs . . . . . . . . . . . . . .       (29,316)       (28,262)
     Other, net  . . . . . . . . . . . . . . . . . . . . . . . . .        21,264         17,806
    Other, net . . . . . . . . . . . . . . . . . . . . . . . . . .        (2,956)        (5,135)
                                                                      ----------     ----------
Net cash flows from operating activities . . . . . . . . . . . . .       117,229         81,809
                                                                      ----------     ----------
Cash flows from investing activities:
  Capital expenditures, net  . . . . . . . . . . . . . . . . . . .       (50,078)       (43,114)
  Acquisition of businesses  . . . . . . . . . . . . . . . . . . .        (2,014)             -
  Other investments. . . . . . . . . . . . . . . . . . . . . . . .        (3,000)             -
Insurance investments:
    Purchases. . . . . . . . . . . . . . . . . . . . . . . . . . .      (223,877)      (230,281)
    Proceeds on maturities . . . . . . . . . . . . . . . . . . . .        43,703         25,291
    Proceeds on sales prior to maturity  . . . . . . . . . . . . .        87,181        104,619
                                                                      ----------     ----------
Net cash flows from investing
 activities  . . . . . . . . . . . . . . . . . . . . . . . . . . .      (148,085)      (143,485)
                                                                      ----------     ----------
Cash flows from financing activities:
  Additions to debt, net . . . . . . . . . . . . . . . . . . . . .        17,455         16,213
  Payment of cash dividends  . . . . . . . . . . . . . . . . . . .       (21,690)       (21,240)
  Treasury stock acquisitions. . . . . . . . . . . . . . . . . . .       (30,648)        (3,971)
  Insurance premiums received  . . . . . . . . . . . . . . . . . .       212,944        215,941
  Insurance benefits paid  . . . . . . . . . . . . . . . . . . . .      (118,645)      (103,368)
                                                                      ----------     ----------
Net cash flows from financing
 activities  . . . . . . . . . . . . . . . . . . . . . . . . . . .        59,416        103,575
                                                                      ----------     ----------
Net increase in cash and
 cash equivalents. . . . . . . . . . . . . . . . . . . . . . . . .        28,560         41,899

Cash and cash equivalents:
 At beginning of period  . . . . . . . . . . . . . . . . . . . . .       171,343        120,359 
                                                                      ----------     ----------
 At end of period  . . . . . . . . . . . . . . . . . . . . . . . .    $  199,903     $  162,258
                                                                      ----------     ----------
                                                                      ----------     ----------
</TABLE>

See Notes to Consolidated Financial Statements


                                        4

<PAGE>

Hillenbrand Industries, Inc. and Subsidiaries
Consolidated Balance Sheet
<TABLE>
<CAPTION>

ASSETS                                                                 06/01/96       12/02/95
                                                                      ----------     ----------
                                                                          (In Thousands)
<S>                                                                   <C>            <C>
Current assets:
  Cash and cash equivalents . . . . . . . . . . . . . . . . . . . .   $  199,903     $  171,343
  Trade receivables . . . . . . . . . . . . . . . . . . . . . . . .      300,282        313,483
  Inventories . . . . . . . . . . . . . . . . . . . . . . . . . . .      104,142        111,679
  Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .       44,919         43,660
                                                                      ----------     ----------
   Total current assets . . . . . . . . . . . . . . . . . . . . . .      649,246        640,165

Equipment leased to others, net . . . . . . . . . . . . . . . . . .       98,042         91,329
Property, net . . . . . . . . . . . . . . . . . . . . . . . . . . .      262,714        275,730

Other assets:
  Intangible assets, net . . . . . . . . . . . . . . .  . . . . . .      152,918        162,993
  Other assets  . . . . . . . . . . . . . . . . . . . . . . . . . .       57,876         49,076
                                                                      ----------     ----------
   Total other assets . . . . . . . . . . . . . . . . . . . . . . .      210,794        212,069
Insurance assets:
  Investments . . . . . . . . . . . . . . . . . . . . . . . . . . .    1,455,938      1,432,222
  Deferred  policy acquisition costs  . . . . . . . . . . . . . . .      368,646        339,330
  Deferred income taxes . . . . . . . . . . . . . . . . . . . . . .       65,783         39,518
  Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .       41,895         39,893
                                                                      ----------     ----------
   Total insurance assets . . . . . . . . . . . . . . . . . . . . .    1,932,262      1,850,963
                                                                      ----------     ----------
Total assets  . . . . . . . . . . . . . . . . . . . . . . . . . . .   $3,153,058     $3,070,256
                                                                      ----------     ----------
                                                                      ----------     ----------

LIABILITIES

Current liabilities:
  Short-term debt . . . . . . . . . . . . . . . . . . . . . . . . .   $   59,041     $   40,450
  Current portion of long-term debt . . . . . . . . . . . . . . . .        1,809          2,315
  Trade accounts payable  . . . . . . . . . . . . . . . . . . . . .       54,839         70,743
  Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .      192,572        187,213
                                                                      ----------     ----------
   Total current liabilities. . . . . . . . . . . . . . . . . . . .      308,261        300,721
Other liabilities:
  Long-term debt. . . . . . . . . . . . . . . . . . . . . . . . . .      206,153        206,783
  Other long-term liabilities . . . . . . . . . . . . . . . . . . .       76,530         79,343
  Deferred income taxes . . . . . . . . . . . . . . . . . . . . . .       15,702         14,945
                                                                      ----------     ----------
   Total other liabilities. . . . . . . . . . . . . . . . . . . . .      298,385        301,071
Insurance liabilities:
  Benefit reserves. . . . . . . . . . . . . . . . . . . . . . . . .    1,333,820      1,252,737
  Unearned revenue. . . . . . . . . . . . . . . . . . . . . . . . .      487,854        454,763
  General liabilities . . . . . . . . . . . . . . . . . . . . . . .       19,238         15,200
                                                                      ----------     ----------
   Total insurance liabilities. . . . . . . . . . . . . . . . . . .    1,840,912      1,722,700
                                                                      ----------     ----------
Total liabilities . . . . . . . . . . . . . . . . . . . . . . . . .    2,447,558      2,324,492
                                                                      ----------     ----------
Commitments and contingencies (Note 5)
SHAREHOLDERS' EQUITY
  Common stock. . . . . . . . . . . . . . . . . . . . . . . . . . .        4,442          4,442
  Additional paid-in capital. . . . . . . . . . . . . . . . . . . .       13,745         13,238
  Retained earnings . . . . . . . . . . . . . . . . . . . . . . . .      921,419        876,133
  Accumulated unrealized gain (loss) on
   investments. . . . . . . . . . . . . . . . . . . . . . . . . . .      (22,455)        22,861
  Foreign currency translation adjustment . . . . . . . . . . . . .        3,585         14,099
  Treasury stock  . . . . . . . . . . . . . . . . . . . . . . . . .     (215,236)      (185,009)
                                                                      ----------     ----------
   Total shareholders' equity . . . . . . . . . . . . . . . . . . .      705,500        745,764
                                                                      ----------     ----------
Total liabilities and
 shareholders' equity . . . . . . . . . . . . . . . . . . . . . . .   $3,153,058     $3,070,256
                                                                      ----------     ----------
                                                                      ----------     ----------
</TABLE>

See Notes to Consolidated Financial Statements


                                        5

<PAGE>

Hillenbrand Industries, Inc. and Subsidiaries

Notes to Consolidated Financial Statements
(Dollars in thousands)

1.   Basis of Presentation

     The unaudited, condensed consolidated financial statements appearing in
     this quarterly report on Form 10-Q should be read in conjunction with the
     financial statements and notes thereto included in the Company's latest
     annual report.  Certain information and footnote disclosures normally
     included in financial statements prepared in accordance with generally
     accepted accounting principles have been condensed or omitted.  The
     statements herein have been prepared in accordance with the Company's
     understanding of the instructions to Form 10-Q.  In the opinion of
     management, such financial statements include all adjustments necessary to
     present fairly the financial position, results of operations, and cash
     flows, for the interim periods.

2.   Supplementary Income Statement Information

     Investment income (non-insurance) in the second quarter of 1996 and 1995
     was $4,065 and $3,307, respectively.  Investment income in the first six
     months of 1996 and 1995 was $8,019 and $6,159, respectively.

3.   Supplementary Balance Sheet Information

     The following information pertains to non-insurance assets and consolidated
     shareholders' equity:
                                                    06/01/96         12/02/95
                                                    --------         --------
     Allowance for possible losses and
        discounts on trade receivables..........    $ 17,852         $ 19,833

     Accumulated depreciation of equipment
        leased to others and property...........    $570,360         $544,000

     Accumulated amortization of intangible
        assets..................................    $167,747         $163,836

     Capital Stock:
        Preferred stock, without par value:
          Authorized 1,000,000 shares;
            Shares issued.......................      None             None
        Common stock, without par value:
          Authorized 199,000,000 shares;
            Shares issued.......................  80,323,912       80,323,912


                                        6

<PAGE>

4.   Earnings per Common Share

     Earnings per common share were computed by dividing net income by the
     average number of common shares outstanding during each period (69,782,956
     for the three months of 1996; 69,957,023 for the six months of 1996;
     70,798,713 for the three months of 1995; and 70,841,730 for the six months
     of 1995).  Under a program begun in 1983, the Company has acquired to date
     12,417,972 shares of common stock of which 1,544,835 shares have been
     reissued for general corporate purposes.  The remaining treasury stock has
     been excluded in determining the average number of shares outstanding
     during each period.  Common share equivalents arising from shares awarded
     under the Senior Executive Compensation Program which was initiated in
     fiscal year 1978 and various deferred share equivalents have also been
     excluded from the computation because of their insignificant dilutive
     effect.

5.   Contingencies

     As discussed under Item 3 of the Company's Annual Report on Form 10-K for
     the fiscal year ended December 2, 1995, Hillenbrand Industries, Inc., and
     its subsidiary Hill-Rom Company, Inc., are the subject of an antitrust suit
     brought by a competitor in the health care equipment market.  The plaintiff
     seeks monetary damages totaling in excess of $268.5 million, trebling of
     any damages that may be allowed by the court, and injunctions to prevent
     further alleged unlawful activities.  The Company believes that the claims
     are without merit and is aggressively defending itself against all
     allegations.  There was no material change in the status of this litigation
     during the quarter ended June 1, 1996.

     The Company has voluntarily entered into remediation agreements with
     environmental authorities, and has been issued Notices of Violation
     alleging violations of certain permit conditions.  Accordingly, the Company
     is in the process of implementing plans of abatement in compliance with
     agreements and regulations.  The Company has also been notified as a
     potentially responsible party in investigations of certain offsite disposal
     facilities.  The cost of all plans of abatement and waste site cleanups in
     which the Company is currently involved is not expected to exceed $10.0
     million.  The Company has provided adequate reserves in its financial
     statements for these matters.  Changes in environmental law might affect
     the Company's future operations, capital expenditures and earnings.  The
     cost of complying with these provisions is not known.

     The Company is subject to various other claims and contingencies arising
     out of the normal course of business, including those relating to
     commercial transactions, product liability, safety, health, taxes,
     environmental and other matters.  Management believes that the ultimate
     liability, if any, in excess of amounts already provided or covered by
     insurance, is not likely to have a material adverse effect on the Company's
     financial condition, results of operations or cash flows.


                                        7

<PAGE>

6.   Subsequent Event

     On July 3, 1996, the Company signed a definitive agreement with I-Flow
     Corp. to sell substantially all of the assets of its wholly owned
     subsidiary, Block Medical, Inc.  The agreement is subject to government and
     financing approval and satisfaction of additional conditions.


ITEM 2.    MANAGEMENT'S DISCUSSION AND ANALYSIS OF
           FINANCIAL CONDITION AND RESULTS OF OPERATIONS

RESULTS OF OPERATIONS

SECOND QUARTER 1996 COMPARED WITH SECOND QUARTER 1995

Consolidated net revenues of $424.2 million were up $19.3 million, or 4.8%. 
Health Care sales increased $5.8 million, or 4.2%, due primarily to higher 
unit sales of the Advance-Registered Trademark- series beds at Hill-Rom.  
Sales were lower in Germany.  Sales at Medeco Security Locks were down 
overall due to lower shipments in route management.  In Medeco's door 
security business, strong domestic dealer demand and institutional business 
offset weaker export sales.  Health Care rental revenue increased $2.1 
million, or 2.3%.  In the long-term care market, units in use and average 
rental rates were higher than in the second quarter of 1995.  In the acute 
care market, units in use and rates were down marginally.  While units in use 
in the home care market were up year over year, growth was hampered by recent 
changes in Medicare policy which eliminated reimbursement for certain of 
Hill-Rom's pressure ulcer prevention products.  Funeral Services sales were 
up $1.7 million, or 1.3%, due to a first quarter price increase, marginally 
higher casket unit volume and higher sales of Options-TM- cremation caskets 
and urns.  These gains were largely offset by an increase in the percentage 
of sales derived from lower priced products.  Insurance revenues grew $9.8 
million, or 22.4%, to $53.4 million in the second quarter.  Earned premium 
revenue was up due to a greater number of policies in force year over year.  
Investment income was up due to a larger investment portfolio, partially 
offset by a marginally lower portfolio yield.

Gross profit on Health Care sales of $59.5 million increased $8.9 million, or 
17.6%, due primarily to higher sales of Advance-Registered Trademark- series 
beds, partially offset by increased losses in Europe and lower shipments at 
Medeco. As a percentage of revenues, gross profit was 41.4% compared with 
36.7% in 1995. Margins in 1995 were negatively affected by lower electric bed 
shipments and increased sales of lower margin used furniture.  Gross profit 
on rental revenues of $34.4 million grew $5.1 million, or 17.3%, and as a 
percentage of revenues improved from 31.7% to 36.4%.  This improvement 
reflected lower therapy unit service costs, partially offset by higher 
depreciation.  Funeral Services gross profit of $62.1 million increased $210 
thousand, or 0.3%, and as a percentage of sales declined from 47.2% to 46.8% 
due to increased shipments of lower priced caskets.  Insurance gross profit 
of $13.1 million was up $2.3 million, or 21.0%. Improvements in the 
commission and product structure and higher investment income offset growth 
in benefits and credited interest on the larger base of insurance in force.

                                        8

<PAGE>

Other operating expenses increased $4.3 million, or 4.1%, and as a percentage of
revenues were 25.6% compared with 25.8% in 1995.  Cost control throughout all
operations offset increased incentive compensation expense (reflecting improved
performance) and higher legal fees.

Interest expense increased $882 thousand, or 16.2%, due to higher debt
associated with European operations.

Other income, net, of $2.3 million was essentially unchanged from the second
quarter of 1995.  Higher investment income was mostly offset by other items.

The Company's consolidated effective income tax rate of 40.2% compares with
38.2% in the second quarter of 1995.  This increase was largely due to increased
operating losses in Europe for which the Company is not currently deriving any
tax benefit.  This trend began to develop toward the middle of 1995 and,
combined with lower U.S. earnings, was reflected in a higher effective rate in
the third quarter.

SIX MONTHS ENDED JUNE 1, 1996 COMPARED WITH SIX MONTHS ENDED JUNE 3, 1995

Except as noted below, the factors affecting second quarter comparisons also
affected year to date comparisons.

Consolidated net revenues were up 7.1% to $858.1 million.  Health Care sales 
increased $24.0 million, or 8.9%, on the strength of Advance-Registered 
Trademark- series bed shipments and, in the first quarter, higher sales in 
Germany and favorable exchange rates.  Sales were down in France in the first 
quarter and on a year to date basis.  Sales at Medeco were flat year over 
year. Health Care rental revenue was up $7.1 million, or 3.9%.  The increase 
of 5.5% in the first quarter was not sustainable in the second quarter due to 
the aforementioned change in Medicare reimbursement policy.  Funeral Services 
sales were 3.1% higher through six months.  The decline in product mix 
primarily affected second quarter sales.  Insurance revenues increased $17.8 
million, or 20.2%.

Gross profit on Health Care sales and rentals increased $14.1 million and 
$11.5 million, respectively, and as a percentage of revenues improved 1.7 and 
4.9 percentage points.  Funeral Services gross profit was up $3.9 million, or 
3.2%.  As a percentage of sales it was unchanged at 46.6% due to the decline 
in product mix in the second quarter.  Insurance gross profit increased $4.1 
million, or 19.8%.

Other operating expenses of $220.0 million were up $11.9 million, or 5.7%.

The $2.6 million increase in other income, net, was due primarily to higher 
investment income generated by higher levels of interest earning assets.

                                        9

<PAGE>

LIQUIDITY AND CAPITAL RESOURCES

Net cash flows from operating activities and selected borrowings represent 
the Company's primary sources of funds for growth of the business, including 
capital expenditures and acquisitions.  Cash and cash equivalents (excluding 
the investments of insurance operations) grew from $171.3 million at the end 
of 1995 to $199.9 million at the end of the second quarter.  Net cash flows 
from operating activities of $117.2 million were up $35.4 million due 
primarily to higher earnings and a decrease in net working capital.  
Inventories declined $7.5 million versus a $17.5 million increase through the 
second quarter of 1995.  The 1995 increase reflected additional product 
evaluation inventory at Hill-Rom. The decline in 1996 was due to higher first 
and second quarter shipments at Hill-Rom.  Annualized inventory turns on 
sales improved from 9.6 at year end to 10.8 at quarter end.  Accounts 
receivable days sales outstanding were 73 at the end of the second quarter 
versus 80 at year end 1995.

Capital spending of $50.1 million was higher than in the first six months of
1995 due to increased production of therapy rental units and expenditures
relative to improving operations in Europe.  Investment purchases in insurance
operations reflected funds available from the sale of investments prior to
maturity as Forethought continues to realign its portfolio to better match
maturities with expected policy benefit payments.

In the first quarter, the Company utilized short-term borrowings at a 
favorable interest rate to pay down certain debt in Europe.  Additional debt 
capacity allows the Company considerable flexibility in the funding of future 
growth in all operations.  Insurance premiums received were down marginally 
compared with the first half of 1995.  The policy and commission changes (and 
resulting decline in policy sales) previously discussed were implemented in 
the second quarter of 1995.  The increase in benefits paid primarily reflects 
increased insurance in force year over year.

FACTORS THAT MAY AFFECT FUTURE RESULTS

U.S. acute care capital shipments and orders were steady through the second
quarter.  However, the long-term strength of future order patterns remains
uncertain.  Changes in Medicare reimbursement policy negatively affected Hill-
Rom's rental revenues beginning in the second quarter.  This trend will
continue.  Losses in certain European operations will continue throughout 
1996.


                                       10

<PAGE>

                           PART II - OTHER INFORMATION


ITEM 4.   SUBMISSION OF MATTERS TO A VOTE OF
          SECURITY HOLDERS

The Company held its Annual Meeting of shareholders on April 9, 1996.  Matters
voted upon by proxy were:  the election of four directors nominated for three
year terms expiring in 1999 and the ratification of the Board of Directors'
appointment of Price Waterhouse as independent auditors for the Company.

                                               Voted       Withheld/     Broker
                                                For        Abstained    Non-Vote
                                                ---        ---------    --------
Election of directors in Class III for
  terms expiring in 1999:

John C. Hancock                              61,943,170     436,469        0
George M. Hillenbrand II                     61,944,247     435,392        0
John A. Hillenbrand II                       61,944,852     434,787        0
Lonnie M. Smith                              61,923,622     456,017        0

Mssrs. Peter F. Coffaro, Edward S. Davis, Leonard Granoff and W August
Hillenbrand will continue to serve as Class I directors and Messrs. Lawrence R.
Burtschy, Daniel A. Hillenbrand and Ray J. Hillenbrand will continue to serve as
Class II directors.

                                       Voted        Voted    Withheld/    Broker
                                        For        Against   Abstained  Non-Vote
                                        ---        -------   ---------  --------
Proposal to ratify Price Waterhouse
  as the Company's independent
  auditors:                          62,142,155    168,464     69,020        0



ITEM 6.   EXHIBITS AND REPORTS ON FORM 8-K


B.   Reports on Form 8-K

     There were no reports filed on Form 8-K during the second quarter
     ended June 1, 1996.


                                       11

<PAGE>

                                   SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.

                                        HILLENBRAND INDUSTRIES, INC.

DATE:  July 10, 1996                    BY:   /S/   Tom E. Brewer
                                              -----------------------------
                                                    Tom E. Brewer
                                                    Chief Financial Officer


DATE:  July 10, 1996                    BY:   /S/   James D. Van De Velde
                                              -----------------------------
                                                    James D. Van De Velde
                                                    Controller


                                       12

<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          NOV-30-1996
<PERIOD-END>                               JUN-01-1996
<CASH>                                         199,903
<SECURITIES>                                         0
<RECEIVABLES>                                  318,134
<ALLOWANCES>                                    17,852
<INVENTORY>                                    104,142
<CURRENT-ASSETS>                               649,246
<PP&E>                                         931,116
<DEPRECIATION>                                 570,360
<TOTAL-ASSETS>                               3,153,058
<CURRENT-LIABILITIES>                          308,261
<BONDS>                                        206,153
                                0
                                          0
<COMMON>                                         4,442
<OTHER-SE>                                     701,058
<TOTAL-LIABILITY-AND-EQUITY>                 3,153,058
<SALES>                                        562,310
<TOTAL-REVENUES>                               858,057
<CGS>                                          319,010
<TOTAL-COSTS>                                  519,289
<OTHER-EXPENSES>                               219,998
<LOSS-PROVISION>                                 1,650
<INTEREST-EXPENSE>                              12,557
<INCOME-PRETAX>                                112,000
<INCOME-TAX>                                    45,024
<INCOME-CONTINUING>                             66,976
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    66,976
<EPS-PRIMARY>                                      .96
<EPS-DILUTED>                                      .96
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission